190
Views
22
CrossRef citations to date
0
Altmetric
Review

Analytical tools and evaluation strategies for nanostructured lipid carrier-based topical delivery systems

, , &
Pages 963-992 | Received 08 Mar 2020, Accepted 19 May 2020, Published online: 20 Jul 2020

References

  • Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global Skin Disease Morbidity and Mortality: an Update From the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406–412.
  • Puglia C, Blasi P, Rizza L, et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm. 2008;357(1–2):295–304.
  • Schafer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59(6):427–443.
  • Doktorovova S, Souto EB. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review. Expert Opin Drug Deliv. 2009;6(2):165–176.
  • Pitaksuteepong T. Nanotechnology: effective topical delivery systems. Asian J Pharm Sci. 2016;11(1):16–17.
  • Raza K, Kumar M, Kumar P, et al. Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems. Biomed Res Int. 2014;2014:406731.
  • Souto EB, Muller RH. Cosmetic features and applications of lipid nanoparticles (SLN ®, NLC®). Int J Cosmet Sci. 2008;30(3):157–165.
  • Teeranachaideekul V, Boonme P, Souto EB, et al. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release. 2008;128(2):134–141.
  • Gonzalez-Mira E, Nikolić S, Garcia M, et al. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci. 2011;100(1):242–251.
  • Doktorovova S, Kovacevic AB, Garcia ML, et al. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2016;108:235–252.
  • Rigon RB, Goncalez ML, Severino P, et al. Solid lipid nanoparticles optimized by 2 (2)factorial design for skin administration: cytotoxicity in NIH3T3 fibroblasts. Colloids Surf B Biointerfaces. 2018;171:501–505.
  • Carbone C, Teixeira MDC, Sousa MDC, et al. Clotrimazole-Loaded Mediterranean Essential Oils NLC: A Synergic Treatment of Candida Skin Infections. Pharmaceutics. 2019;11(5):231.
  • Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1–2):121–128.
  • Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–184.
  • Mahant S, Rao R, Nanda S. Nanostructured lipid carriers: revolutionizing skin care and topical therapeutics. In: Grumezescu AM, editors. Design of Nanostructures for Versatile Therapeutic Applications: William Andrew Publishing. 2018. p. 97–136.
  • Arif T, Nisa N, Amin SS, et al. Therapeutic and diagnostic applications of nanotechnology in dermatology and cosmetics. J Nanomed Biotherapeutic Discovery. 2015;5:1.
  • Doktorovova S, Silva AM, Gaivão I, et al. Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles. J Appl Toxicol. 2014;34(4):395–403.
  • Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87(1):1–18.
  • Junyaprasert VB, Teeranachaideekul V, Souto EB, et al. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm. 2009;377(1–2):207–214.
  • Yoon G, Park JW, Yoon I-S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Invest. 2013;43(5):353–362.
  • Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv. 2012;9(4):429–441.
  • Shidhaye S, Vaidya R, Sutar S, et al. Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv. 2008;5(4):324–331.
  • MAHANT S, KUMAR S, PAHWA R, et al. SOLID LIPID NANOPARTICLES IN DRUG DELIVERY FOR SKINCARE. Nanopart Drug Deliv Syst. 2019;337-367.
  • Muller RH, Petersen RD, Hommoss A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522–530.
  • Zhang Z, Tsai PC, Ramezanli T, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(3):205–218.
  • Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci. 2010;99(1):21–50.
  • Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev. 2004;56(5):675–711.
  • Beloqui A, Solinis MA, Rodriguez-Gascon A, et al. Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine. 2016;12(1):143–161.
  • Guy RH, Hadgraft J. Transdermal drug delivery. New York. U.S.A. CRC Press; 2003.
  • , Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN (R), NLC (R)) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol. 2007;3:317-331.
  • Higuchi W, Higuchi T. Theoretical analysis of diffusional movement through heterogeneous barriers. J Am Pharm Assoc. 1960;49(9):598–606.
  • Moser K, Kriwet K, Kalia YN, et al. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. Int J Pharm. 2001;224(1–2):169–176.
  • Alvarez-Román R, Naik A, Kalia Y, et al. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm. 2004;58(2):301–316.
  • Toll R, Jacobi U, Richter H, et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123(1):168–176.
  • Iqbal MA, Md S, Sahni JK, et al. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 2012;20(10):813–830.
  • Souto E, Müller R. Challenging cosmetics: solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). In: editors, Wiechers J, Kozlowski A. Science and Applications of Skin Delivery Systems. Vol. Chapter 13. Carol Stream, Chicago, USA: Allured Publishing; 2008. p. 230-250.
  • Jaiswal P, Gidwani B, AJAc V. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif cells nanomed biotechnol. 2014;44:27–40.
  • Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2–3):165–196.
  • Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12(1):62–76.
  • Svilenov H, Tzachev C. Solid lipid nanoparticles—A promising drug delivery system. Nanomedicine. 2014;8:188–237.
  • Müller R, Runge S, Ravelli V, et al. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm. 2006;317(1):82–89.
  • Teeranachaideekul V, Muller RH, Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)–effects of formulation parameters on physicochemical stability. Int J Pharm. 2007;340(1–2):198–206.
  • Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release. 2008;128(3):185–199.
  • Lin YK, Huang ZR, Zhuo RZ, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine. 2010;5:117–128.
  • Uprit S, Kumar Sahu R, Roy A, et al. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 2013;21(4):379–385.
  • Tichota DM, Silva AC, Sousa Lobo JM, et al. Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration. Int J Nanomedicine. 2014;9:3855–3864.
  • Tokton N, Ounaroon A, Panichayupakaranant P, et al. Development of ellagic acid rich pomegranate peel extract loaded nanostructured lipid carriers (NLCS). Int J Pharm Sci. 2014;6:259–265.
  • Kong X, Zhao Y, Quan P, et al. Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier. Asian J Pharm Sci. 2016;11(2):248–254.
  • Qidwai A, Khan S, Md S, et al. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv. 2016;23(4):1476–1485.
  • Tsai MJ, Wu PC, Huang YB, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm. 2012;423(2):461–470.
  • Anantachaisilp S, Smith SM, Treetong A, et al. Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution. Nanotechnology. 2010;21(12):125102.
  • Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 2008;346(1–2):124–132.
  • Phatak AA, Chaudhari PD. Development and evaluation of nanostructured lipid carrier (NLC) based topical delivery of an anti-inflammatory drug. J Pharm Res. 2013;7(8):677–685.
  • Pamudji JS, Mauludin R, Indriani N. Development of nanostructured lipid carrier formulation containing of retinyl palmitate. Int J Pharm Pharm Sci. 2016;8:0975–1491.
  • Han F, Yin R, Che X, et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm. 2012;439(1–2):349–357.
  • Chen PC, Huang J-W, Pang J. An investigation of optimum NLC-sunscreen formulation using taguchi analysis. J Nanomater. 2013;2013:9.
  • Souto E, Wissing S, Barbosa C, et al. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm. 2004;58(1):83–90.
  • Averina ES, Seewald G, Müller RH, et al. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil. Pharmazie. 2010;65(1):25–31.
  • Choi W-S, Cho H-I, Lee H-Y, et al. Enhanced occlusiveness of nanostructured lipid carrier (NLC)-based carbogel as a skin moisturizing vehicle. J Pharm Invest. 2010;40:373–378.
  • Sachan AK, Gupta A, Arora M. FORMULATION & CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIER (NLC) BASED GEL FOR TOPICAL DELIVERY OF ETORICOXIB. J Drug Deliv Therap. 2016;6(2):4–13.
  • Souto EB, Müller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006;23(4):377–388.
  • Rahman HS, Rasedee A, How CW, et al. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine. 2013;8:2769–2781.
  • Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 2007;59(6):379–402.
  • Dumas J, Zeraouli Y, Strub M. Heat transfer inside emulsions. Determination of the DSC thermograms. part 1. crystallization of the undercooled droplets. Thermochim Acta. 1994;236:227–237.
  • Höhne G, Hemminger WF, Flammersheim H-J. Differential scanning calorimetry. New York. Springer Science & Business Media; 2013.
  • Radtke M, Müller RH. Nanostructured lipid drug carriers. New Drugs. 2001;2:48–52.
  • Xia Q, Saupe A, Müller R, et al. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci. 2007;29(6):473–482.
  • Yang Y, Corona A 3rd, Schubert B, et al. The effect of oil type on the aggregation stability of nanostructured lipid carriers. J Colloid Interface Sci. 2014;418:261–272.
  • Pradhan M, Singh D, Murthy SN, et al. Design, characterization and skin permeating potential of fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Steroids. 2015;101:56–63.
  • Müller RH, Runge SA, Ravelli V, et al. Cyclosporine-loaded solid lipid nanoparticles (SLN®): drug–lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm. 2008;68(3):535–544.
  • Araujo J, Gonzalez-Mira E, Egea MA, et al. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm. 2010;393(1–2):167–175.
  • Aji Alex MR, Chacko AJ, Jose S, et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 2011;42(1–2):11–18.
  • Kasongo W, Pardeike J, Müller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100(12):5185–5196.
  • Stodghill SP. Thermal analysis: a review of techniques and applications in the pharmaceutical sciences. Am Pharm Rev. 2010;13:29.
  • Vyazvokin S. Thermogravimetric Analysis. In: Kaufmann EN, editor. Characterization of materials. Wiley. 2012. p.1–12.
  • Wu P-S, Lin C-H, Kuo Y-C, et al. Formulation and characterization of hydroquinone nanostructured lipid carriers by homogenization emulsification method. J Nanomater. 2017;2017:1–7.
  • Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285–308.
  • Üner M-A. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie. 2006;61:375–386.
  • Liedtke S, Zimmermann E, Müller R, et al. Physical characterisation of solid lipid nanoparticles (SLNTM). Proc Int Symp Control Release Bioact Mater. 1999;26:595-596.
  • Jores K, Mehnert W, Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res. 2003;20:1274–1283.
  • Blaschke T, Kankate L, Kramer K. Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. Adv Drug Deliv Rev. 2007;59(6):403–410.
  • Sivaramakrishnan R, Nakamura C, Mehnert W, et al. Glucocorticoid entrapment into lipid carriers—characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release. 2004;97(3):493–502.
  • Borgia SL, Regehly M, Sivaramakrishnan R, et al. Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 2005;110(1):151–163.
  • Bumbrah GS, Sharma R. Raman spectroscopy–Basic principle, instrumentation and selected applications for the characterization of drugs of abuse. Egypt J Forensic Sci. 2016;6:209–215.
  • Joshi M, Patravale V. Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm. 2006;32(8):911–918.
  • Teeranachaideekul V, Souto E, Müller R, et al. Effect of surfactant on the physical and chemical stability of ascorbyl palmitate-loaded NLC system.AAPS Annual Meeting and Exposition (Nashville, USA); 2005.
  • Teeranachaideekul V, Souto EB, Muller RH, et al. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). J Microencapsul. 2008;25(2):111–120.
  • Katoh K, Asimenos G, Toh H. Multiple alignment of DNA sequences with MAFFT. In: Posada D, editor. Bioinformatics for DNA sequence analysis. Springer; 2009. p. 39–64.
  • Kyadarkunte AY, Patole MS, Pokharkar VB. Cellular interactions and photoprotective effects of idebenone-loaded nanostructured lipid carriers stabilized using PEG-free surfactant. Int J Pharm. 2015;479(1):77–87.
  • Luepke NJF, Toxicology C. Hen’s egg chorioallantoic membrane test for irritation potential. Food Chem Toxicol. 1985;23:287–291.
  • McKenzie B, Kay G, Matthews KH, et al. The hen’s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: quantification using photoshop® and imagej. Int J Pharm. 2015;490:1–8.
  • Savian AL, Rodrigues D, Weber J, et al. Dithranol-loaded lipid-core nanocapsules improve the photostability and reduce the in vitro irritation potential of this drug. Mater Sci Eng C Mater Biol Appl. 2015;46:69–76.
  • Wissing S, Lippacher A, Muller R. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci. 2001;52(5):313–324.
  • Lippacher A, Muller RH, Mader K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm. 2001;214(1–2):9–12.
  • Jeon HS, Seo JE, Kim MS, et al. A retinyl palmitate-loaded solid lipid nanoparticle system: effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo. Int J Pharm. 2013;452(1–2):311–320.
  • Puglia C, Damiani E, Offerta A, et al. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies. Eur J Pharm Sci. 2014;51:211–217.
  • Silva A, Amaral M, González-Mira E, et al. Solid lipid nanoparticles (SLN)-based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies. Colloids Surf B Biointerfaces. 2012;93:241–248.
  • Castelli F, Puglia C, Sarpietro MG, et al. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm. 2005;304(1–2):231–238.
  • Marcato PD, Duran N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol. 2008;8(5):2216–2229.
  • Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm. 2006;314:83–89.
  • Kaur S, Nautyal U, Singh R, et al. Nanostructure lipid carrier (NLC): the new generation of lipid nanoparticles. Asian Pac J Health Sci. 2015;2(2):76–93.
  • Patel D, Dasgupta S, Dey S, et al. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci Pharm. 2012;80(3):749–764.
  • Ghate VM, Lewis SA, Prabhu P, et al. Nanostructured lipid carriers for the topical delivery of tretinoin. Eur J Pharm Biopharm. 2016;108:253–261.
  • Antonio JR, Antonio CR, Cardeal ILS, et al. Nanotechnology in dermatology. An Bras Dermatol. 2014;89(1):126–136.
  • Lohani A, Verma A, Joshi H, et al. Nanotechnology-based cosmeceuticals. ISRN Dermatol. 2014;2014:1–14.
  • Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
  • Organization WH. Dermal absorption EHC 235. WHO Press, World Health Organization. Geneva, Switzerland; 2006.
  • Zsikó S, Cutcher K, Kovács A, et al. Nanostructured lipid carrier gel for the dermal application of lidocaine: comparison of skin penetration testing methods. Pharmaceutics. 2019;11:310.
  • Shen CY, Dai L, Shen BD, et al. Nanostructured lipid carrier based topical gel of ganoderma triterpenoids for frostbite treatment. Chin J Nat Med. 2015;13(6):454–460.
  • Ricci M, Puglia C, Bonina F, et al. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci. 2005;94(5):1149–1159.
  • Nagaich U, Gulati N. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Deliv Transl Res. 2016;6(3):289–298.
  • Lin CH, Fang YP, Al-Suwayeh SA, et al. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull. 2013;36(2):276–286.
  • Simonart T. Immunotherapy for acne vulgaris: current status and future directions. Am J Clin Dermatol. 2013;14:429–435.
  • Kim JJD. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211:193–198.
  • Elmowafy M, Shalaby K, Ali HM, et al. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies. Int J Pharm. 2019;572:118781.
  • Kumari S, Pandita D, Poonia N, et al. Nanostructured lipid carriers for topical delivery of an anti-acne drug: characterization and ex vivo evaluation. Pharm Nanotechnol. 2015;3(2):122–133.
  • Jain A, Garg NK, Jain A, et al. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Drug Dev Ind Pharm. 2016;42(6):897–905.
  • Lacatusu I, Istrati D, Bordei N, et al. Synergism of plant extract and vegetable oils-based lipid nanocarriers: emerging trends in development of advanced cosmetic prototype products. Mater Sci Eng. 2020;108:110412.
  • Suresh PK, Singh P, Saraf S. Novel topical drug carriers as a tool for treatment of psoriasis: progress and advances. Afr J Pharm Pharmacol. 2013;7(5):138–147.
  • Boehncke W-HJRDC. Etiology and pathogenesis of psoriasis. Rheum Dis Clin North Am. 2015;41:665–675.
  • Greb JE, Goldminz AM, Gottlieb ABJCI. Insights on methotrexate in psoriatic disease. J Clin Immunol. 2016;172:61–64.
  • Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 2010;401(1–2):93–102.
  • Arora R, Katiyar SS, Kushwah V, et al. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin Drug Deliv. 2017;14(2):165–177.
  • Sathe P, Saka R, Kommineni N, et al. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev Ind Pharm. 2019;45:826–838.
  • Sharma A, Upadhyay DK, Sarma GS, et al. Squalene integrated NLC based gel of tamoxifen citrate for efficient treatment of psoriasis: A preclinical investigation. J Drug Deliv Sci Tec. 2020;56:101568.
  • Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev. 2002;123(7):801–810.
  • Sadick NS, Karcher C, Palmisano L. Cosmetic dermatology of the aging face. Clin Dermatol. 2009;27(3):S3–S12.
  • Sudel KM, Venzke K, Mielke H, et al. Novel aspects of intrinsic and extrinsic aging of human skin: beneficial effects of soy extract. Photochem Photobiol. 2005;81(3):581–587.
  • Salavkar SM, Tamanekar RA, Athawale RB. Antioxidants in skin ageing–Future of dermatology. Int J Green Pharm\(IJGP). 2011;5:161-168.
  • Jain P, Rahi P, Pandey V, et al. Nanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effects. Egypt J Basic Appl Sci. 2017;4(2):89–100.
  • Vinardell MP, Mitjans M. Nanocarriers for delivery of antioxidants on the skin. Cosmetics. 2015;2(4):342–354.
  • Singh Hallan S, Sguizzato M, Pavoni G, et al. Ellagic acid containing nanostructured lipid carriers for topical application: a preliminary study. Molecules. 2020;25:1449.
  • Leelapornpisid P, Chansakaow S, Na-Boonlong S, et al. Development of cream containing nanostructured lipid carriers loaded marigold (tagetes erecta linn.) flowers extract for anti-wrinkles application. Int J Pharm Pharm Sci. 2014;6:313–314.
  • Gokce EH, Korkmaz E, Dellera E, et al. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine. 2012;7:1841–1850.
  • Bruge F, Damiani E, Puglia C, et al., Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions. Int J Pharm. 2013;455(1–2): 348–356.
  • Nayak K, Katiyar SS, Kushwah V, et al. Coenzyme Q10 and retinaldehyde co-loaded nanostructured lipid carriers for efficacy evaluation in wrinkles. J Drug Target. 2018;26(4):333–344.
  • Liu X, Zhang R, Shi H, et al. Protective effect of curcumin against ultraviolet A irradiationinduced photoaging in human dermal fibroblasts. Mol Med Rep. 2018;17(5):7227–7237.
  • Blasi P, Schoubben A, Giovagnoli S, et al. The real value of novel particulate carriers for sunscreen formulation. Exp Rev Dermatol. 2011;6(5):509–517.
  • Chen YL, Xia Q. Preparation and characterization of broad-spectrum sunscreens loaded nanostructured lipid carrier. advanced materials research. Trans Tech Publ. 2013.669:67-71.
  • Salunkhe SS, Bhatia NM, Pokharkar VB, et al. Topical delivery of Idebenone using nanostructured lipid carriers: evaluations of sun-protection and anti-oxidant effects. J Pharm Invest. 2013;43(4):287–303.
  • Wood C, Murphy E. Sunscreen efficacy. Global Cosmet Indus. 2000;167:38–43.
  • Wolf R, Tuzun B, Tuzun Y. Sunscreens. Dermatol Therapy. 2001;14(3):202–214.
  • Dutra EA, Oliveira D, Kedor-Hackmann ERM, et al. Determination of sun protection factor (SPF) of sunscreens by ultraviolet spectrophotometry. Revista Brasileira De Ciências Farmacêuticas. 2004;40(3):381–385.
  • Gulbake A, Jain A, JainS K. Development of nanostructured lipid carrier as potential sun protectant. Nanosci Nanotechnol Asia. 2012;2(2):210–216.
  • Badea G, Badea N, Brasoveanu LI, et al. Naringenin improves the sunscreen performance of vegetable nanocarriers. New J Chem. 2017;41(2):480–492.
  • Dianzani C, Zara GP, Maina G, et al. Drug delivery nanoparticles in skin cancers. Biomed Res Int. 2014;2014:1–13.
  • Gieseler F, Rudolph P, Kloeppel G, et al. Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail? Int J Colorectal Dis. 2003;18(6):470–480.
  • Powis G. Toxicity of anticancer drugs to humans: aunique opportunity to study human toxicology. In: Powis G & Hacker MP, editors. Toxic Anticancer Drugs. New York. Pergamon Press. 1991;1:1-9.
  • Tipton J. Side effects of cancer chemotherapy. In: Skeel RT, editor. Handbook of cancer chemotherapy. Lippincot Williams and Wilkins. Vol. 561. 2003. p. 580.
  • Rajinikanth PS, Chellian J. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. Int J Nanomedicine. 2016;11:5067–5077.
  • Singh P, Singh M, Kanoujia J, et al. Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line. Drug Deliv Transl Res. 2016;6(5):597–609.
  • Tavakol Afshari J, Yousefi M, Salari R. Atopic dermatitis and the therapeutic methods: a literature review. Rev Clinl Med. 2016;3:158–162.
  • Fan H, Liu G, Huang Y, et al. Development of a nanostructured lipid carrier formulation for increasing photo-stability and water solubility of phenylethyl resorcinol. Appl Surf Sci. 2014;288:193–200.
  • Tofani RP, Sumirtapura YC, Darijanto ST. Formulation, characterisation, and in vitro skin diffusion of nanostructured lipid carriers for deoxyarbutin compared to a nanoemulsion and conventional cream. Sci Pharm. 2016;84(4):634–645.
  • Hussain Z, Thu HE, Ng SF, et al. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art. Colloids Surf B Biointerfaces. 2017;150:223–241.
  • Saporito F, Sandri G, Bonferoni MC, et al. Essential oil-loaded lipid nanoparticles for wound healing. Int J Nanomedicine. 2018;13:175–186.
  • Alalaiwe A, Wang PW, Lu PL, et al. Synergistic Anti-MRSA activity of cationic nanostructured lipid carriers in combination with oxacillin for cutaneous application. Front Microbiol. 2018;9:1493.
  • Fatima N, Rehman S, Nabi B, et al. Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. J Drug Deliv Sci Tec. 2019;54:101253.
  • Hanna PA, Ghorab MM, Gad SJA-I, et al. Development of betamethasone dipropionate-loaded nanostructured lipid carriers for topical and transdermal delivery. Antiiinflam Antiallergy Agents Med Chem. 2019;18:26–44.
  • Kaur N, Sharma K, Bedi N. Topical nanostructured lipid carrier based hydrogel of mometasone furoate for the treatment of psoriasis. Pharm Nanotechnol. 2018;6(2):133–143.
  • Madan JR, Khobaragade S, Dua K, et al. Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast. Dermatol Ther. 2020;2020:7.
  • Viegas JSR, Praça FG, Caron AL, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646-660 .
  • Wang H, Xia Q, Tang J, et al. Preparation, characterization and antioxidative activity of anti-aging nanoemulsion and lipid nanoparticles.Tech Connect Briefs. 2011;3:248-251.
  • KUMAR P, SINGH A. Nanostructured lipid carriers (NLCS): a prominent topical delivery system for coenzyme q10 and myrica esculenta leaves extract for anti-aging potentIAL. International Journal of Pharmacy and Pharmaceutical Sciences. 2018;10(8):106.
  • Rosita N, Haryadi DM, Erawati T, et al. Photostability study on character and antioxidant activity of tomato extract (solanum lycopersicum l.) in nanostructured lipid carrier (NLC) and conventional creame. Int J Drug Delivery Technol. 2017;7(1):71–74.
  • Chen S, Liu W, Wan J, et al. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm. 2013;39(1):20–28. .
  • Sanad RA, Abdelmalak NS, Elbayoomy TS, et al. Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). AAPS PharmSciTech. 2010;11(4):1684–1694.
  • Niculae G, Lacatusu I, Badea N, et al. Optimization of lipid nanoparticles composition for sunscreen encapsulation. UPB Sci Bull Ser B. 2013;75:79–92.
  • Mănescu I GBadea G, Iscrulescu L, Lovu M, Balaci T. Incorporation of new benzimidazole compounds into lipid nanostructures in order to obtain photoprotective formulations. Farmacia. 2015;63:518–525.
  • Lima PA, Rampazo CA, Costa AF, et al. Natural lipids in nanostructured lipid carriers and its cytotoxicity. J Phys: Conf Ser. 2017;838:1-8.
  • Lacerda SP, Cerize NN, Re MI. Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone-3. Int J Cosmet Sci. 2011;33(4):312–321.
  • Deng X, Xia Q. Lipid nanoparticles as novel carrier for broad-spectrum sunscreen formulations. Santa Clara, CA; 2012.
  • Rosseto HC, Toledo LAS, Francisco LMB, et al. Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2017;158:441–452.
  • Motawea A, Borg T, Abd El-Gawad AEH. Topical phenytoin nanostructured lipid carriers: design and development. Drug Dev Ind Pharm. 2018;44(1):144–157.
  • Garcia-Orue I, Gainza G, Girbau C, et al. LL37 loaded nanostructured lipid carriers (NLC): a new strategy for the topical treatment of chronic wounds. Eur J Pharm Biopharm. 2016;108:310–316.
  • Gainza G, Bonafonte DC, Moreno B, et al. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model. J Control Release. 2015;197:41–47.
  • Khezri K, Farahpour MR. Mounesi rad SJAc, nanomedicine, biotechnology. accelerated infected wound healing by topical application of encapsulated rosemary essential oil into nanostructured lipid carriers. Artif Cells Nanomed Biotechnol. 2019;47:980–988.
  • Zhao J, Piao X, Shi X, et al. Podophyllotoxin-loaded nanostructured lipid carriers for skin targeting: in vitro and in vivo studies. Molecules. 2016;21(11):1549.
  • Almousallam M, Moia C, Zhu H. Development of nanostructured lipid carrier for dacarbazine delivery. Int Nano Lett. 2015;5(4):241–248.
  • Iqbal B, Ali J, Ganguli M, et al. Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer. Nanomedicine. 2019;14:1077–1093.
  • Souto EB, Baldim I, Oliveira WP, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin Drug Del. 2020;17(3):1–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.